Icon

ATRIPLA (nda021937)- (600MG;200MG;300MG)

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE GILEAD SCIENCES
600MG;200MG;300MG
Yes No
2029-Apr-28 Expired
None None
None No
ATRIPLA is a three-drug combination of efavirenz (EFV), a nonnucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
8 2 6
Total Other Developers 7
Drugs with Suitability No
600MG;200MG;300MG ** ** - 6 -
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** **** *** * ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** **-**, ****** ** *** ******* ********** ****** ********, *****, ***** ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. *-*, *-**, *-** *** *-**/*/*, ********** ********** ****, ******, *********** ******, ***** (***) ***
****** ***** ******* *********** *********** *** ****** *** ******, ********, ******** *** ***, ****** (***) ***
****** ****** ****** **** ******* *** *********** **** **. **, ** & **, ******* ****** ***** *********** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***
****** ****** ****** **** ******* *********** **** **. **, ** & **, ******* ****** ***** *********** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.